Werewolf Therapeutics (HOWL)
(Delayed Data from NSDQ)
$2.94 USD
+0.20 (7.30%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $2.94 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.39 |
Last EPS Surprise | -11.43% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.52 |
Next Year | -1.73 |
EPS (TTM) | -1.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.00M | 2.00M | 13.57M | 25.50M |
# of Estimates | 1 | 1 | 3 | 2 |
High Estimate | 2.00M | 2.00M | 27.00M | 50.00M |
Low Estimate | 2.00M | 2.00M | 6.70M | 1.00M |
Year ago Sales | 8.08M | 5.90M | 19.94M | 13.57M |
Year over Year Growth Est. | -75.25% | -66.10% | -31.98% | 87.97% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.37 | -1.52 | -1.73 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | -0.43 | -0.44 | -1.49 | -3.00 |
High Estimate | -0.29 | -0.30 | -1.34 | -0.91 |
Low Estimate | -0.43 | -0.44 | -1.72 | -3.00 |
Year ago EPS | -0.14 | -0.23 | -1.05 | -1.52 |
Year over Year Growth Est. | -171.43% | -60.87% | -44.76% | -14.08% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.37 | -1.52 | -1.73 |
7 Days Ago | -0.38 | -0.37 | -1.52 | -1.73 |
30 Days Ago | -0.38 | -0.37 | -1.52 | -1.73 |
60 Days Ago | -0.38 | -0.37 | -1.52 | -1.73 |
90 Days Ago | -0.29 | -0.16 | -1.38 | -1.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.37 | -1.52 | -1.73 |
Zacks Consensus Estimate | -0.38 | -0.37 | -1.52 | -1.73 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.39 | -0.33 | -0.23 | -0.14 | NA |
Estimate | -0.35 | -0.43 | -0.27 | -0.41 | NA |
Difference | -0.04 | 0.10 | 0.04 | 0.27 | 0.09 |
Surprise | -11.43% | 23.26% | 14.81% | 65.85% | 23.12% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more